Compound ID | 734
Class: Oxazolidinone
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Activity against H. influenzae, S. pneumoniae and S. aureus |
Institute where first reported: | Pharmacia &Upjohn ; Pharmacia Corp.; Pfizer, USA |
Year first mentioned: | 1999 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
External links: | |
Citation: |